Ratings
0
Nobody has rated this yet. Be the first!
Works
2
TP53 Mutation Status Divides MDS Patients with Complex Karyotypes into Distinct Prognostic Risk Groups: Analysis of Combined Datasets from the International Working Group for MDS-Molecular Prognosis Committee
Clinical and biological implications of driver mutations in myelodysplastic syndromes
